AzTrials
AzTrials

Suicide IdeationNCT06882798

A New Clinical Model for the Engagement of Latinx Youth With Suicidal Behavior

A study testing Socio-Cognitive Behavioral Therapy for Suicidal Behavior (SCBT-SB) and SCBT-SB + CHW in people with Suicide Ideation and Suicidal Behaviors, run by Bradley Hospital at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study will test a model of providing treatment to Latinx/Hispanic youth, who experience suicidal thoughts and behavior, and their caregivers. An affirmative and culturally relevant treatment will be provided to all youth and half of the families will be assigned to the additional support of a community health… Read more about this study

Who is it for?
Ages 12 to 18 years
What is being tested?
Socio-Cognitive Behavioral Therapy for Suicidal Behavior (SCBT-SB) and SCBT-SB + CHW
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteUnited States
Study dates
28 Mar 2024to Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Latinx, defined as have been born in a Latin country or having at least one biological parent, grandparent or an ancestor that was born in a Latin country
  • Severe Suicidal Ideation (SI), defined as one of the following:
  • SIQ-JR > 22 or endorsing any critical items (2, 3, 4, 7, 8, 9) with at least "about 1x/month"
  • CDI-II > 15 and endorsing "I think about killing myself but would not do it" OR "I think about killing myself."
  • PHQ-9 > 10 \& endorsing the item "Thoughts that you would be better off dead, or of hurting yourself in some way" with a frequency of "several days" or greater or endorsing the item "Has there been a time in the past month when you have had serious thoughts about ending your life?
  • Suicidal crisis within the past 12 months
  • Caregivers and adolescents fluent in Spanish or English language and legal guardian willing to participate

Who cannot join

  • Participants will be referred to a different treatment program if their main clinical complaint is any of the following:
  • Behavioral (e.g., conduct disorder, or substance use disorder)
  • An eating disorder
  • Obsessive-compulsive disorder
  • A developmental issue (e.g., speech, occupational, families looking for assessments, treatment for autism) or a significant cognitive delay that may require specialized treatment adjustments.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Yovanska Duarte-Velez, PhD contact

401-432-1651

yovanska.duart-velez@brownhealth.org

Gisela Jimenez-Colon, PhD contact

+1 (401) 432-1059

gjimenezcolon@brownhealth.org

United States1 site, 1 recruiting
  • Bradley Hasbro Children's Research Center

    Providence, Rhode Island, 02903

    Yovanska Duarte-Velez, PhD, 401-432-1651, yovanska.duart-velez@brownhealth.org

    Gisela Jimenez-Colon, PhD, 401-432-1059, gjimenezcolon@brownhealth.org

    Recruiting

Other trials in United States

About this study

Official title: A New Clinical Model for the Engagement of Latinx Youth With Suicidal Behavior and Their Families in a Culturally Centered CBT Treatment

This study will test a model of providing treatment to Latinx/Hispanic youth, who experience suicidal thoughts and behavior, and their caregivers. An affirmative and culturally relevant treatment will be provided to all youth and half of the families will be assigned to the additional support of a community health worker (CHW). Youth symptoms and family engagement to treatment will be followed for nine months. The potential benefit of adding the CHW intervention will be assessed.

Read the detailed description

The objective of this proposal is to test a New Clinical Model to engage Latinx/Hispanic (L/H) youth and their caregivers in a culturally centered, evidence-based treatment for suicidal behaviors (SB). The Socio-Cognitive Behavioral Therapy for Suicidal Behavior (SCBT-SB) is an affirmative and culturally relevant treatment with empirical evidence supporting its use for L/H youth with suicidality. The New Clinical Model consists of the addition of community health workers (CHWs) to the SCBT-SB. CHWs are trusted members of their communities who provide education and connection to resources to L/H families in their native language. A community based participatory research approach is proposed and the Socio-Cultural Framework for Health Service Disparities will be the theoretical model used.

Being tested
Socio-Cognitive Behavioral Therapy for Suicidal Behavior (SCBT-SB), SCBT-SB + CHW
Keywords
Suicidal Ideation, Suicide Attempt, Randomized controlled trial, adolescents, Latinx, Latina, Latino, Hispanic, cognitive behavioral therapy, depressive symptoms, community health workers
Medical subject headings
Depression, Suicidal Ideation, Suicide, Attempted

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Socio-Cognitive Behavioral Therapy for Suicidal Behavior (SCBT-SB)Behavioural

    SCBT-SB is a manualized psychosocial treatment protocol developed specifically with and for L/H youth with suicidal ideation and behaviors. Clinician, adolescents, and caregivers' manuals are available in both Spanish and English. SCBT-SB protocol's main conceptual framework and strategies are informed by Cognitive Behavioral Therapy concepts, psychoeducation, and adolescent parenting strategies. The intervention involves individual, caregivers, and family sessions. SCBT-SB, while maintaining the basic principles of CBT, was further developed to include developmental (e.g., identity), and cultural elements of L/H families (e.g., family communication, language). The protocol has two main phases. Phase 1, the Crisis Module, includes nine standard core sessions, and Phase 2, which proposes a flexible number of sessions, focused on the delivery of interchangeable coping skills modules and the acquisition of skills that reduce STB.

  • SCBT-SB + CHWBehavioural

    The New Clinical Model consist of one clinician delivering the SCBT-SB and one CHW per each family. The assigned clinician \& CHW will meet at the beginning of treatment to discuss their assigned case and will have follow-up meetings as needed and at a minimum, once monthly. CHWs will support family engagement in treatment. CHWs will assess each family's social needs and concerns about treatment. The CHW intervention will 1) Assess social determinants of mental health; 2) Provide referrals and serve as a bridge to other community resources; 3) Provide psychoeducation on mental health and services to decrease stigma; and 4) Follow-up and provide support on recommended actions.

Study groups in NCT06882798
Study groupRoleWhat they receive
SCBT-SB (Only)Active comparatorA culturally centered CBT treatment protocol called Socio-Cognitive Behavioral Therapy for Suicidal Behavior (SCBT-SB)
Receives: Behavioral: Socio-Cognitive Behavioral Therapy for Suicidal Behavior (SCBT-SB)
New Clinical Model: SCBT-SB + Community Health WorkerExperimentalSCBT-SB treatment with the additional support of a community health worker (CHW)
Receives: Behavioral: SCBT-SB + CHW

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Suicidal Ideation (SI)

    Suicidal ideation measured using the Suicide Ideation Questionnaire-Junior (SIQ-JR), a self-report instrument of 15 items that measures severity of suicidal ideation as a continuous variable with established normative, reliability, and validity data for clinical and non-clinical adolescent samples. The minimum score is 0 and the maximum 90. A higher score represents increased severity and frequency of suicidal thoughts.

    Measured: Change from baseline to 6 months and baseline to 9 months.

  2. Suicide Attempts (SA)

    Actual and interrupted suicide attempts (yes or no) using the Columbia-Suicide Severity Rating Scale (C-SSRS).

    Measured: Change from baseline to 6 months, 6 months to 9 months, and baseline to 9 months.

  3. Suicidal Events (SE)

    SE is defined as yes or no to any suicide attempt plus any ER visits due to suicidal ideation, and suicidal threats based on patient's own report and medical record, or by information gathered from the Child and Adolescent Services Assessment (CASA).

    Measured: Change from baseline to 6 months, 6 months to 9 months, and baseline to 9 months.

  4. Depressive symptoms by self-report

    Level of depressive symptomatology using the Children Depression Inventory 2 (CDI-2). The CDI uses 27 items with a 4-point Likert type scale, the minimum score is 0 and the maximum 56. It evaluates symptoms such as depressive mood, hedonic capacity, vegetative sign, self-evaluation, and interpersonal behaviors. A higher score means higher level of depressive symptoms.

    Measured: Change from baseline to 6 months and baseline to 9 months.

  5. Depressive symptoms by clinical interview

    Depressive symptoms using the Children's Depression Rating Scale-Revised (CDRS-R). The CDRS-R is a 17-item interview assessment of depressive symptoms for school aged children and adolescents, with item rating between 1 (no difficulties) to 5 or 7 (clinically significant difficulties). The minimum raw score is 17 and the maximum 113. A higher score means higher level of depressive symptoms. It has been proposed that a score of ≥40 indicates depressive symptomatology comparable to a diagnosis of depression, whereas a score ≤28 was often used as indicative of remission within trials.

    Measured: Change from baseline to 6 months and baseline to 9 months.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Mar 2025
  2. Study start28 Mar 2024
  3. Primary completionJan 2027 (estimated)
  4. Study completionJan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06882798
Sponsor's protocol ID
STR-1-138-22
Status last verified
Mar 2025
First submitted
17 Mar 2025
Last updated
19 Mar 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Basic demographics and outcome measures will be uploaded to the NIMH Data Archive with a data dictionary.

Publications

  • Duarte-Velez Y, Torres-Davila P, Spirito A, Polanco N, Bernal G. Development of a treatment protocol for Puerto Rican adolescents with suicidal behaviors. Psychotherapy (Chic). 2016 Mar;53(1):45-56. doi: 10.1037/pst0000044.

    PubMed 26928136
  • Jimenez-Colon G, Duarte-Velez Y. Raising Children in Different Cultures: Working with Latinx Youth with Suicidal Behaviors and Their Families. R I Med J (2013). 2022 May 2;105(4):31-35.

    PubMed 35476733
  • Duarte-Velez Y, Jimenez-Colon G, Jones RN, Spirito A. Socio-Cognitive Behavioral Therapy for Latinx Adolescent with Suicidal Behaviors: A Pilot Randomized Trial. Child Psychiatry Hum Dev. 2024 Jun;55(3):754-767. doi: 10.1007/s10578-022-01439-z. Epub 2022 Oct 1.

    PubMed 36183051

Questions about this trial

What is this clinical trial studying?

A study testing Socio-Cognitive Behavioral Therapy for Suicidal Behavior (SCBT-SB) and SCBT-SB + CHW in people with Suicide Ideation and Suicidal Behaviors, run by Bradley Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 19 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yovanska Duarte-Velez, PhD (401-432-1651, yovanska.duart-velez@brownhealth.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Suicidal Ideation (SI) (time frame: Change from baseline to 6 months and baseline to 9 months.). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06882798, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in